Center D M, Cruikshank W W, Berman J S, Beer D J
J Immunol. 1983 Oct;131(4):1854-9.
Mitogens and antigens have been the traditional ligands for activating lymphocytes in vitro for the elaboration of lymphokines. Recently, histamine, by interaction with histamine-type 2 receptors on T lymphocytes, has been found to induce the production of one lymphokine, histamine-induced suppressor factor (HSF), that inhibits lymphocyte proliferation and lymphokine production in vitro. Because the biologic effects of HSF appear to be confined to alterations in lymphocyte function, we assessed the ability of soluble products of histamine-stimulated human blood mononuclear cells to affect another lymphocyte function, motility. Utilizing a modified Boyden chamber assay to assess lymphocyte migration, we identified chemoattractant activity for human blood and rat splenic T lymphocytes in histamine-induced mononuclear cell supernatants. No neutrophil or monocyte chemoattractant activity was present. Sephadex G-100 gel filtration of histamine-induced supernatants showed the lymphotactic activity eluted with a 56,000 m.w. This activity was cationic as determined by its elution pattern from a Sephadex QAE anion exchange matrix with a single pl of 9.0 to 9.4 determined by isoelectric focusing in sucrose. Its biologic activity is predominantly chemokinetic in nature, is stable to heating at 56 degrees C for 30 min, but is sensitive to the effects of trypsin and neuraminidase. These physicochemical and functional characteristics establish it as identical to a recently described concanavalin A-induced (Con A) lymphotactic lymphokine (LCF). Mononuclear cells that did not adhere to a histamine affinity matrix were unable to produce LCF when subsequently stimulated with histamine or Con A. Mononuclear cells incubated with histamine and diphenhydramine produced LCF; the addition of cimetidine eliminated LCF production. In fact, supernatants from cells incubated with histamine and cimetidine significantly inhibited lymphocyte migration, a phenomenon explainable by the two regions of lymphocyte migration inhibitory activity that were present in the Sephadex G-100 chromatography of crude histamine-induced supernatants. These data suggest that a subset of lymphocytes defined by the presence of histamine-type 2 receptors is capable of producing LCF while cells that bear histamine-type 1 receptors produce lymphocyte migration inhibitory activity.
有丝分裂原和抗原一直是体外激活淋巴细胞以产生淋巴因子的传统配体。最近发现,组胺通过与T淋巴细胞上的组胺2型受体相互作用,可诱导一种淋巴因子——组胺诱导抑制因子(HSF)的产生,该因子在体外可抑制淋巴细胞增殖和淋巴因子产生。由于HSF的生物学效应似乎仅限于淋巴细胞功能的改变,我们评估了组胺刺激的人血单核细胞的可溶性产物影响另一种淋巴细胞功能——运动性的能力。利用改良的Boyden小室分析法评估淋巴细胞迁移,我们在组胺诱导的单核细胞上清液中鉴定出了对人血和大鼠脾T淋巴细胞的趋化活性。不存在中性粒细胞或单核细胞趋化活性。组胺诱导的上清液经Sephadex G - 100凝胶过滤显示,淋巴趋化活性在分子量56,000处洗脱。通过其在Sephadex QAE阴离子交换基质上的洗脱模式确定该活性为阳离子性,通过在蔗糖中进行等电聚焦测定其单一的等电点为9.0至9.4。其生物学活性本质上主要是化学促动性的,在56℃加热30分钟稳定,但对胰蛋白酶和神经氨酸酶的作用敏感。这些理化和功能特性表明它与最近描述的伴刀豆球蛋白A诱导(Con A)的淋巴趋化淋巴因子(LCF)相同。未附着于组胺亲和基质的单核细胞在随后用组胺或Con A刺激时无法产生LCF。与组胺和苯海拉明一起孵育的单核细胞产生LCF;加入西咪替丁则消除LCF产生。实际上,与组胺和西咪替丁一起孵育的细胞的上清液显著抑制淋巴细胞迁移,这一现象可由粗制组胺诱导的上清液在Sephadex G - 100层析中存在的两个淋巴细胞迁移抑制活性区域来解释。这些数据表明,由组胺2型受体的存在所定义的一部分淋巴细胞能够产生LCF,而带有组胺1型受体的细胞则产生淋巴细胞迁移抑制活性。